Novo Nordisk A S (NONOF) stock
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Novo Nordisk A S cash
Cash and short-term investments held at the end of each period.
Novo Nordisk A S's cash was 26.46B DKK at Dec 31, 2025. For fiscal 2025 it was 26.46B DKK, up 69.0% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is 26.46B DKK in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26.46B DKK | +69.0% |
| FY2024 | Dec 31, 2024 | 15.66B DKK | +8.8% |
| FY2023 | Dec 31, 2023 | 14.39B DKK | +13.7% |
| FY2022 | Dec 31, 2022 | 12.65B DKK | +18.0% |
| FY2021 | Dec 31, 2021 | 10.72B DKK | -12.3% |
| FY2020 | Dec 31, 2020 | 12.23B DKK | -20.7% |
| FY2019 | Dec 31, 2019 | 15.41B DKK | -1.4% |
| FY2018 | Dec 31, 2018 | 15.63B DKK | -8.9% |
| FY2017 | Dec 31, 2017 | 17.16B DKK | -7.1% |
| FY2016 | Dec 31, 2016 | 18.46B DKK | +16.5% |
| FY2015 | Dec 31, 2015 | 15.85B DKK | +15.9% |
| FY2014 | Dec 31, 2014 | 13.68B DKK | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 26.46B DKK | +146.9% |
| Q4 FY2024 | Dec 31, 2024 | 15.66B DKK | +28.0% |
| Q4 FY2023 | Dec 31, 2023 | 14.39B DKK | -6.6% |
| Q4 FY2022 | Dec 31, 2022 | 12.65B DKK | -19.0% |
| Q4 FY2021 | Dec 31, 2021 | 10.72B DKK | -37.5% |
| Q4 FY2020 | Dec 31, 2020 | 12.23B DKK | -33.8% |
| Q4 FY2019 | Dec 31, 2019 | 15.41B DKK | -2.8% |
| Q4 FY2018 | Dec 31, 2018 | 15.63B DKK | +14.3% |
| Q4 FY2017 | Dec 31, 2017 | 17.16B DKK | – |
| Q4 FY2016 | Dec 31, 2016 | 18.46B DKK | – |
| Q4 FY2015 | Dec 31, 2015 | 15.85B DKK | – |
| Q4 FY2014 | Dec 31, 2014 | 13.68B DKK | – |
See a number that looks wrong?